0 إشارة هذا الأسبوع
0
اجتماعي
أخبار
مدونة
Moderna and Merck cancer vaccine cuts melanoma recurrence by 44% in late-stage trial
قبل ٦ي
Moderna and Merck vaccine cuts melanoma recurrence risk by 44% in phase 3 study
